Atea Pharmaceuticals EPS Diluted (Quarterly) Trends

Atea Pharmaceuticals Inc (AVIR)

3.25 +0.09 (+2.85%) USD | NASDAQ | Nov 21, 16:00

3.24 -0.01 (-0.31%) After-Hours: 20:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
September 30, 2024	-0.37
June 30, 2024	-0.48
March 31, 2024	-0.75
December 31, 2023	-0.47
September 30, 2023	-0.40
June 30, 2023	-0.34
March 31, 2023	-0.43
December 31, 2022	-0.41
September 30, 2022	-0.10
June 30, 2022	-0.38
March 31, 2022	-0.51

Date	Value
December 31, 2021	1.34
September 30, 2021	-0.34
June 30, 2021	0.02
March 31, 2021	0.34
December 31, 2020	0.2506
September 30, 2020	-0.2224
June 30, 2020	-0.2113
March 31, 2020	-0.0843
December 31, 2019	-0.0984
September 30, 2019	-0.0768

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-0.75

Minimum

Mar 2024

1.34

Maximum

Dec 2021

-0.1823

Average

-0.34

Median

Sep 2021

EPS Diluted (Quarterly) Benchmarks

McKesson Corp	1.87
Pfizer Inc	0.78
Doximity Inc	0.22
Immuneering Corp	-0.49
CEL-SCI Corp	-0.14

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	-31.15M
Total Expenses (Quarterly)	37.20M
Enterprise Value	-208.31M
Earnings Yield	-63.69%
Operating Earnings Yield	50.68%
Normalized Earnings Yield	41.85